SGI 1027 10mg 10mg | Purity Not Available
Adooq Bioscience
SGI 1027 is a DNMT inhibitor with IC50 of 6, 8, 7.5 ??M for DNMT1, DNMT3A, and DNMT3B, respectively.
More Information Supplier PageSearch Results
FR 180204 50mg 50mg | Purity Not Available
Adooq Bioscience
FR 180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis.
More Information Supplier PageFR 180204 25mg 25mg | Purity Not Available
Adooq Bioscience
FR 180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis.
More Information Supplier PageFR 180204 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
FR 180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis.
More Information Supplier PageFR 180204 10mg 10mg | Purity Not Available
Adooq Bioscience
FR 180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis.
More Information Supplier PageYH239-EE 50mg 50mg | Purity Not Available
Adooq Bioscience
YH239-EE 25mg 25mg | Purity Not Available
Adooq Bioscience
SGI 1027 25mg 25mg | Purity Not Available
Adooq Bioscience
SGI 1027 is a DNMT inhibitor with IC50 of 6, 8, 7.5 ??M for DNMT1, DNMT3A, and DNMT3B, respectively.
More Information Supplier PageSGI 1027 50mg 50mg | Purity Not Available
Adooq Bioscience
SGI 1027 is a DNMT inhibitor with IC50 of 6, 8, 7.5 ??M for DNMT1, DNMT3A, and DNMT3B, respectively.
More Information Supplier PageCTX 0294885 10mg 10mg | Purity Not Available
Adooq Bioscience
CTX-0294885 is a novel broad-spectrum kinase inhibitor. CTx-0294885 exhibits inhibitory activity against a broad range of kinases in vitro.
More Information Supplier Page